ReviewInflammation

SMAC mimetics and RIPK inhibitors as therapeutics for chronic inflammatory diseases

See allHide authors and affiliations

Science Signaling  18 Feb 2020:
Vol. 13, Issue 619, eaax8295
DOI: 10.1126/scisignal.aax8295

Log in to view full text

Log in through your institution

Log in through your institution

Stay Connected to Science Signaling

Navigate This Article